Likewise, the key activator NF-κB plays a critical role in inflammation and CA-CRC, and inactivation of the NF-κB activating kinase or TNFα, the upstream activator of NF-κB) results in reduced tumor burden [25, 26]. Here, NFKB1 is linked to neoplasm.